Colitis, Ulcerative
222
30
45
119
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
59 trials with published results (27%)
Research Maturity
119 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.4%
23 terminated out of 222 trials
83.8%
-2.8% vs benchmark
21%
47 trials in Phase 3/4
50%
59 of 119 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 119 completed trials
Clinical Trials (222)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
A Study to Assess Guselkumab in Participants With Moderate-to-Severe Inflammatory Bowel Disease in Real Life Italian Setting
Confirmatory Clinical Study in Active Ulcerative Colitis
A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Long-term Extension Study of Ustekinumab in Pediatric Participants
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis